Ferrous fumarate is a type of iron supplement commonly used to treat iron deficiency anemia. The global ferrous fumarate market is primarily driven by the increasing prevalence of iron deficiency anemia, particularly among women and children. Additionally, the growing demand for dietary supplements and the rising awareness about the importance of proper nutrition and health are expected to drive market growth. However, the high prevalence of side effects associated with ferrous fumarate supplements, such as constipation and gastrointestinal distress, may hinder market growth. The availability of alternative iron supplements and the low consumer awareness in developing regions are also expected to impact market growth.
The Ferrous Fumarate market is segmented by product form, application, and distribution channel, and is primarily dominated by North America and Europe, with Asia Pacific expected to witness significant growth during the forecast period.
Top Companies in the Ferrous Fumarate Industry:
1. Vifor Pharma
Vifor Pharma is a Swiss pharmaceutical company founded in 2007 and headquartered in St. Gallen, Switzerland. It specializes in the development and production of iron deficiency treatments, including ferrous fumarate. In May 2020, Vifor Pharma announced the acquisition of rights to commercialize a novel iron deficiency treatment in Europe and other international markets.
2. Ironwood Pharmaceuticals
Ironwood Pharmaceuticals is a US-based pharmaceutical company founded in 1998 and headquartered in Cambridge, Massachusetts. It focuses on developing treatments for gastrointestinal and other chronic diseases, including iron deficiency anemia. In March 2021, Ironwood Pharmaceuticals announced the FDA approval of a new treatment for iron deficiency anemia in adults.